Nivolumab is a monoclonal antibody that works by binding to a protein called PD-1 on a type of immune cell called T-cell.

Through the choice of images in publications, women and children of colour in low and middle income countries were treated with less dignity and respect than those in high income countries.

What Matt Slater is hearing about the business side of the beautiful game from the Premier League, EFL and beyond ...

For executives racing to lead in healthcare AI, I see the European Union, the United States and China as the leading ...

RetinAI US Inc. (RetinAI) and Fundación Ver Salud (FVS) are pleased to jointly announce that LuxIA ®, their co-developed innovative AI algorithm for Diabetic Retinopathy (DR) screening, has ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...

Founded by Evan Kervella and Dimitri Labat, Chipiron is working to make MRI technology available in more places and for more people.

From North Korean soldiers in Ukraine to wealthy Americans buying up "escape properties" in a Swiss village, these big ...

Although the definition of acute respiratory distress syndrome (ARDS) has undergone numerous revisions aimed at enhancing its ...

In 2024, measles cases in Europe soared to the highest levels in decades, with over 35,000 reported cases, 87% from Romania ...

Authorities in northern New Mexico released police body camera video and other public records, including photos from inside ... she was researching medical conditions related to COVID-19 and ...

Imricor receives CE Mark certification for the Advantage-MR system under new European Medical Device Regulation Approval follows CE Mark certification for the second-generation Vision-MR Ablation ...